We are live on ! Find out more
IC

IEQ Capital Portfolio holdings

AUM $21.5B
1-Year Est. Return 75.26%
This Fund
S&P 500
This Quarter Est. Return
+20.79%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
AUM
$6.01B
AUM Growth
+$1.1B
Cap. Flow
+$192M
Cap. Flow %
3.2%
Top 10 Hldgs %
40.15%
Holding
1,010
New
71
Increased
466
Reduced
312
Closed
84

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$63.1M
2
RBLX icon
Roblox
RBLX
+$21.2M
3
BRZE icon
Braze
BRZE
+$10.7M
4
MSFT icon
Microsoft
MSFT
+$10M
5
ACCD
Accolade Inc
ACCD
+$9.55M

Sector Composition

Rank Sector Weight
1 Technology 28.71%
2 Communication Services 17.6%
3 Financials 7.52%
4 Consumer Discretionary 6.72%
5 Healthcare 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOE icon
876
BlackRock Enhanced Global Dividend Trust
BOE
$684M
$122K ﹤0.01%
12,255
-16,296
-57% -$157K
XERS icon
877
Xeris Biopharma Holdings
XERS
$1.4B
$118K ﹤0.01%
50,169
JPC icon
878
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$117K ﹤0.01%
+17,340
New +$110K
AGNC icon
879
AGNC Investment
AGNC
$12.6B
$117K ﹤0.01%
+11,932
New +$105K
NBXG
880
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.2B
$113K ﹤0.01%
10,294
+294
+3% +$3.06K
PACB icon
881
Pacific Biosciences
PACB
$404M
$112K ﹤0.01%
11,424
LCID icon
882
Lucid Motors
LCID
$2.61B
$105K ﹤0.01%
+2,488
New +$112K
LYG icon
883
Lloyds Banking Group
LYG
$90.7B
$99.8K ﹤0.01%
41,749
+20,270
+94% +$43.4K
BCS icon
884
Barclays
BCS
$96B
$94.7K ﹤0.01%
+12,015
New +$86.5K
CBIO
885
Crescent Biopharma
CBIO
$586M
$90.5K ﹤0.01%
384
JFR icon
886
Nuveen Floating Rate Income Fund
JFR
$1.24B
$87.2K ﹤0.01%
10,609
-1,218
-10% -$9.73K
AMBP icon
887
Ardagh Metal Packaging
AMBP
$3.04B
$85.5K ﹤0.01%
+22,270
New +$77.5K
UNIT
888
Uniti Group
UNIT
$2.35B
$83.9K ﹤0.01%
14,509
-472
-3% -$2.39K
MRVI icon
889
Maravai LifeSciences
MRVI
$946M
$83.8K ﹤0.01%
12,801
+1,805
+16% +$11.7K
NXDR
890
Nextdoor Holdings
NXDR
$934M
$79.3K ﹤0.01%
41,968
-100
-0.2% -$176
ONCT
891
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$77.4K ﹤0.01%
7,222
UWMC icon
892
UWM Holdings
UWMC
$624M
$74.1K ﹤0.01%
10,360
LILM
893
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$73K ﹤0.01%
61,840
-22,632
-27% -$20.6K
BBD icon
894
Banco Bradesco
BBD
$37.8B
$72.5K ﹤0.01%
20,714
+4,103
+25% +$12.9K
LOGC
895
DELISTED
ContextLogic
LOGC
$70.9K ﹤0.01%
11,917
VAXX
896
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$70.8K ﹤0.01%
+83,262
New +$80.4K
TWOU
897
DELISTED
2U Inc
TWOU
$67.9K ﹤0.01%
1,839
KG
898
Kestrel Group
KG
$68.9M
$67.6K ﹤0.01%
+1,475
New +$54.7K
GNSS icon
899
Genasys
GNSS
$78.8M
$61.7K ﹤0.01%
+30,414
New +$53.9K
NCV
900
Virtus Convertible & Income Fund
NCV
$388M
$61.4K ﹤0.01%
4,555
-6,322
-58% -$79.2K

Similar funds

IEQ Capital's Q4 2023 Portfolio in Review

As of Q4 2023, IEQ Capital held 1,010 positions worth $6.01B, up 22% from $4.92B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

IEQ Capital deployed $192M of net new capital in Q4 2023, opening 71 new positions and adding to 466 existing holdings. Its largest new stake was Accolade Inc: 1,114,691 shares worth $13.4M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was CrowdStrike, an estimated $19.6M trimmed.

  • IEQ Capital's largest Q4 2023 buy was Accolade Inc: 1,114,691 shares worth $13.4M.
  • IEQ Capital added most to Snowflake in Q4 2023, an estimated $63.1M increase.
  • IEQ Capital's biggest Q4 2023 reduction was CrowdStrike, cutting an estimated $19.6M.
  • IEQ Capital fully exited Activision Blizzard in Q4 2023, selling an estimated $2.52M.
  • IEQ Capital's ten largest holdings make up 40% of its $6.01B portfolio in Q4 2023.
  • IEQ Capital opened 71 new positions and closed 84 in Q4 2023.
  • IEQ Capital's portfolio value rose 22% quarter-over-quarter to $6.01B.

Based on IEQ Capital's 13F filing for Q4 2023, filed 7 Feb 2024.